VANTAGEPOINT INVESTMENT ADVISERS LLCVANTAGEPOINT INVESTMENT ADVISERS LLC

Institutional investor · Portfolio as of Q3 2023

SEC EDGAR SourceSEC Filings

Top Holdings9 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
TLTTLT
ETF

ISHARES 20 PLUS YEAR TREASURY BD

2.5M$219.4M35.8%$91.28-14.10%
6 qtrssince 2022-Q2
Increased
64
IVVIVV
ETF

ISHARES CORE S&P 500 ETF

384,970$165.3M27.0%$378.11+10.18%
14 qtrssince 2020-Q2
Increased
66
AGGAGG
ETF

ISHARES TR

1.4M$131.3M21.4%$93.25-9.74%
14 qtrssince 2020-Q2
Unchanged
0
VUGVUG
ETF

VANGUARD GROWTH ETF

135,830$37M6.0%$34.94+28.13%
5 qtrssince 2022-Q3
Unchanged
0
IWFIWF
ETF

ISHARES TR RUSSELL 1000 GROWTH INDEX FUND

74,485$19.8M3.2%$248.00+6.09%
5 qtrssince 2022-Q3
Increased
87
IWDIWD
ETF

ISHARES TR RUSSELL 1000 VALUE INDEX FUND

106,300$16.1M2.6%$143.37+1.47%
6 qtrssince 2022-Q2
Increased
81
IJHIJH
ETF

ISHARES CORE S&P MIDCAP ETF

59,500$14.8M2.4%$46.33+4.27%
4 qtrssince 2022-Q4
Unchanged
0
VTVVTV
ETF

VANGUARD VALUE ETF

36,300$5M0.8%$121.52+7.74%
6 qtrssince 2022-Q2
Unchanged
0
IWRIWR
ETF

ISHARES RUSSELL MIDCAP INDEX FUND

66,200$4.6M0.7%$64.68+3.82%
4 qtrssince 2022-Q4
Unchanged
0
$613.3M
AUM
9
Positions
Q3 2023
Filing
Rating · 1.0
Quarterly Portfolio Change
-8%Q3'22$548.7M+4%Q4'22$573.1M+5%Q1'23$600.2M+10%Q2'23$660.4M-7%Q3'23$613.3M
Activity profile
$ moved · Q3'23
New0%Increased59%Decreased0%Exited41%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.8 years
<1Q0%1-4Q22%1-2Y44%2Y+33%

VANTAGEPOINT INVESTMENT ADVISERS LLC manages $613.3M across 9 positions as of Q3 2023. Top holdings: TLT (35.8%), IVV (27.0%), AGG (21.4%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 1/5.0.

Q3 2023 Summary

Exited 1, increased 4. Top move: IWF (INCREASED, conviction 87). Portfolio: $613M across 9 positions.

Top holdings by portfolio weight

Total AUM$613M
TLT35.77%
IVV26.95%
AGG21.40%
VUG6.03%
IWF3.23%
IWD2.63%
IJH2.42%
VTV0.82%
IWR0.75%
VEA0.00%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Weak(1.0 / 5.0)
Track RecordNo data
Conviction50
Concentration51
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
VUGVUGVANGUARD GROWTH ETF
Q3 2025 Q2 2026+6.8M shares+$581.2M
3Q
AVEMAVEMAVANTIS EMERGING MARKETS EQ
Q4 2025 Q2 2026+126,777 shares+$60.7M
2Q
VWOVWOVANGUARD FTSE EMERGING MARKETS
Q1 2026 Q2 2026+521,392 shares+$44.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used